Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Nebraska
City of Hope Medical Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Gruppo Italiano Malattie EMatologiche dell'Adulto
Case Comprehensive Cancer Center